Retrieve available abstracts of 5 articles: HTML format
Single Articles
October 2025
WATSON OJ, Tran TN, Zupko RJ, Symons T, et al Global risk of selection and spread of Plasmodium falciparum histidine-rich
protein 2 and 3 gene deletions.
Nat Med. 2025 Oct 6. doi: 10.1038/s41591-025-03974. PubMedAbstract available
January 2025
ROOZEN GVT, van Schuijlenburg R, Hensen ADO, Koopman JPR, et al Single immunization with genetically attenuated Pf?mei2 (GA2) parasites by
mosquito bite in controlled human malaria infection: a placebo-controlled
randomized trial.
Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03347. PubMedAbstract available
August 2024
PARKASH V, Ashwin H, Dey S, Sadlova J, et al Safety and reactogenicity of a controlled human infection model of sand
fly-transmitted cutaneous leishmaniasis.
Nat Med. 2024 Aug 2. doi: 10.1038/s41591-024-03146. PubMedAbstract available
April 2024
ISHENGOMA DS, Gosling R, Martinez-Vega R, Beshir KB, et al Urgent action is needed to confront artemisinin partial resistance in African
malaria parasites.
Nat Med. 2024 Apr 25. doi: 10.1038/d41591-024-00028. PubMed
January 2024
BOTTIEAU E, Mbow M, Brosius I, Roucher C, et al Antimalarial artesunate-mefloquine versus praziquantel in African children with
schistosomiasis: an open-label, randomized controlled trial.
Nat Med. 2024 Jan 4. doi: 10.1038/s41591-023-02719. PubMedAbstract available